Investigating how time-restricted eating may lower cancer risk by improving cell function.
Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function
This study is looking at how eating only during certain hours of the day might help lower cancer risk, especially for older adults and those who are at risk of being overweight, and it hopes to show that this way of eating can improve health and metabolism.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Salk Institute for Biological Studies NIH-funded |
| Lab location | 1 site (La Jolla, UNITED STATES) |
| Project ID | NIH-10907699 on NIH RePORTER |
What this research studies
This research explores the effects of time-restricted eating (TRE) on cancer risk, particularly in older adults and those at risk of obesity. By limiting daily food intake to a specific time window, the study aims to understand how this dietary approach can enhance mitochondrial function and potentially reduce cancer incidence. The research involves both animal models and human participants to assess metabolic improvements and cancer outcomes associated with TRE. Participants may experience health benefits related to weight management and metabolic health.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults, particularly those who are overweight or at risk for obesity-related cancers.
Not a fit: Patients who are not overweight or do not have a history of cancer may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary recommendations that significantly lower cancer risk for older adults.
How similar studies have performed: Previous studies have shown promising results with intermittent fasting approaches in reducing cancer risk, suggesting that this research builds on a foundation of encouraging preliminary evidence.
Where this research is happening
La Jolla, UNITED STATES
- Salk Institute for Biological Studies — La Jolla, United States (Active)
Researchers
- Principal investigator: Panda, Satchidananda — Salk Institute for Biological Studies
- Study coordinator: Panda, Satchidananda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.